Table 1.

Circulating miRNAs and miRNA signatures useful for NPC ¹ diagnosis.

miRNA	Method	Biotype	Compared Groups	Reference
BART13-3p; BART9-3p	Sequencing	Serum	NPC vs. HS 2	[52]
13 miRNAs	Sequencing	Plasma	NPC vs. cancer-free	[58]
8-miR	Microarray	Whole blood	NPC vs. HS	[55]
16-miR	Microarray	Whole blood	NPC vs. HNC 3 + HS	[55]
miR-17, miR-20a, miR-29c, miR-223	Microarray	Whole blood	NPC vs. non-cancer donors	[56]
miR-548q; miR-483-5p	Microarray	Plasma	NPC vs. CN 4 controls	[57]
BART7-3p; BART13-3p	RT-qPCR 5	Plasma	NPC vs. non-NPC (HS, CN, HNSCC 6)	[53]
BART2-5p	RT-qPCR	Serum	NPC vs. non-cancer	[54]

¹ NPC, nasopharyngeal cancer; ² HS, healthy subject; ³ HNC, head and neck cancer; ⁴ CN, chronic nasopharyngitis; ⁵ RT-PCR, reverse transcriptase quantitative polymerase chain reaction; ⁶ HNSCC, head and neck squamous cell carcinoma.